Medicare

CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr. Mehmet Oz’s Team and an “Evidence Sprint 2026” Focused on Grants, Research and Clinical Evidence

Houston, Texas--(Newsfile Corp. - January 12, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on...

CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr. Mehmet Oz’s Team and an “Evidence Sprint 2026” Focused on Grants, Research and Clinical Evidence

Houston, Texas--(Newsfile Corp. - January 12, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on...

CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr. Mehmet Oz’s Team and an “Evidence Sprint 2026” Focused on Grants, Research and Clinical Evidence

Houston, Texas--(Newsfile Corp. - January 12, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on...

DiMe launches new initiative to scale trusted, high-impact AI care navigation in response to how patients are already using AI to navigate care

Founding members span Big Tech, healthcare, payers, and patient groups to define what good looks like for trusted AI-enabled care...

New Digital MSK Platform Already has 100+ Million Eligible Members and Offers Savings Upwards of 50-70% Compared to Many Other Digital MSK Offerings!

Solution Provides Self-Guided Tools Broadening Member Options for RecoverySAN DIEGO, Jan. 8, 2026 /PRNewswire/ -- American Specialty Health (ASH), a leader...

Best Semaglutide Options for 2026: New Oral Wegovy Pill Approved by FDA as Patients Compare Injectable and Compounded Access Pathways

Industry Analysis Examines How Cost, Safety, and Access Considerations Shape Semaglutide Choices as MEDVi Lists Compounded Options Alongside New FDA-Approved...

error: Content is protected !!